(PREV-B) Prevas - Ratings and Ratios
Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0000356008
PREV-B: Software design, Industrial automation, Medical devices, Embedded systems, IoT
Prevas AB is a Swedish-based technical consultancy firm with a strong foothold in Europe and beyond. Established in 1985, the company has built a reputation for delivering comprehensive solutions across a wide array of industries, including life science, automotive, energy, and manufacturing. What sets Prevas apart is its deep expertise in integrating cutting-edge technologies like IoT, industrial digitalization, and cybersecurity into legacy systems, helping clients maintain operational efficiency and competitiveness in a rapidly evolving market.
The company’s service portfolio is extensive, covering everything from embedded systems and intelligent sensors to enterprise asset management and industrial cloud solutions. Prevas also specializes in medical technology development, with a strong emphasis on regulatory compliance, including CE marking, FDA registrations, and MDR/IVDR consultations. This makes it a go-to partner for life science companies navigating complex regulatory landscapes. Additionally, Prevas offers automation and robotics solutions, lean design methodologies, and environment and working condition optimization, catering to the diverse needs of its industrial clients.
From a financial perspective, Prevas AB is a mid-cap company with a market capitalization of approximately 1.43 billion SEK. The stock trades on the Stockholm Stock Exchange under the ticker symbol PREV-B. With a P/E ratio of 15.57 and a price-to-book ratio of 2.20, the company offers a balance of growth potential and stability. Its price-to-sales ratio of 0.92 suggests that it is reasonably valued relative to its revenue generation capabilities. These metrics make it an attractive consideration for investors seeking exposure to the IT consulting and industrial technology sectors.
Prevas operates in high-growth industries, and its ability to deliver end-to-end solutions positions it well to capitalize on trends like Industry 4.0 and the increasing demand for digital transformation. The company’s long-standing relationships with clients across sectors such as automotive, energy, and manufacturing underscore its reliability and expertise. For fund managers and investors, Prevas represents a strategic play on the convergence of industrial and technological innovation, with a strong track record of delivering value to its customers and shareholders alike.
Additional Sources for PREV-B Stock
PREV-B Stock Overview
| Market Cap in USD | 134m |
| Sector | Technology |
| Industry | Information Technology Services |
| GiC Sub-Industry | IT Consulting & Other Services |
| IPO / Inception |
PREV-B Stock Ratings
| Growth 5y | 56.9% |
| Fundamental | 1.31% |
| Dividend | 62.4% |
| Rel. Strength Industry | -19.3 |
| Analysts | - |
| Fair Price Momentum | 103.42 SEK |
| Fair Price DCF | 74.25 SEK |
PREV-B Dividends
| Dividend Yield 12m | 4.17% |
| Yield on Cost 5y | 13.47% |
| Annual Growth 5y | 24.14% |
| Payout Consistency | 34.9% |
PREV-B Growth Ratios
| Growth Correlation 3m | -20% |
| Growth Correlation 12m | -45.1% |
| Growth Correlation 5y | 85.1% |
| CAGR 5y | 24.13% |
| CAGR/Max DD 5y | 0.48 |
| Sharpe Ratio 12m | -0.06 |
| Alpha | -22.04 |
| Beta | 0.88 |
| Volatility | 32.45% |
| Current Volume | 7.8k |
| Average Volume 20d | 16.8k |
As of February 22, 2025, the stock is trading at SEK 104.40 with a total of 7,815 shares traded.
Over the past week, the price has changed by -5.43%, over one month by -1.51%, over three months by -0.57% and over the past year by -4.19%.
Neither. Based on ValueRay Fundamental Analyses, Prevas is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 1.31 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PREV-B as of February 2025 is 103.42. This means that PREV-B is currently overvalued and has a potential downside of -0.94%.
Prevas has no consensus analysts rating.
According to ValueRays Forecast Model, PREV-B Prevas will be worth about 124.1 in February 2026. The stock is currently trading at 104.40. This means that the stock has a potential upside of +18.88%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 138 | 32.2% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 124.1 | 18.9% |